Page last updated: 2024-12-09

glucobrassicin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

glucobrassicin: isolated from Brussels sprouts; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

glucobrassicin : An indolylmethylglucosinolic acid that is 1-thio-beta-D-glucopyranose having a 2-(1H-indol-3-yl)-N-(sulfooxy)ethanimidoyl group attached to the anomeric sulfur. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID656506
CHEBI ID29028
MeSH IDM0139062

Synonyms (12)

Synonym
CHEBI:29028
indol-3-ylmethylglucosinolate
3-img
3-indolylmethylglucosinolate
1-s-[2-(1h-indol-3-yl)-n-(sulfooxy)ethanimidoyl]-1-thio-beta-d-glucopyranose
C05837 ,
glucobrassicin
4356-52-9
[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 2-(1h-indol-3-yl)-n-sulfooxyethanimidothioate
glucobrassicin (3-indolmethyl-gs)
Q906037
DTXSID60963046

Research Excerpts

Overview

Glucobrassicin is a predominant glucosinolate. It is the precursor of indole-3-carbinol (I3C), a compound with anticancer effects.

ExcerptReferenceRelevance
"Glucobrassicin is a predominant glucosinolate and is the precursor of indole-3-carbinol (I3C), a compound with anticancer effects."( Urinary 3,3'-diindolylmethane: a biomarker of glucobrassicin exposure and indole-3-carbinol uptake in humans.
Ainslie-Waldman, CE; Carmella, SG; Fan, Y; Fritz, VA; Fujioka, N; Hatsukami, DK; Hecht, SS; Le, C; Rauch, D; Rohwer, C; Upadhyaya, P, 2014
)
1.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
indolyl carbohydrate
indolylmethylglucosinolic acidA glucosinolic acid with a indolylmethyl side-chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (68)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (5.88)18.7374
1990's8 (11.76)18.2507
2000's13 (19.12)29.6817
2010's34 (50.00)24.3611
2020's9 (13.24)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.44 (24.57)
Research Supply Index4.29 (2.92)
Research Growth Index5.10 (4.65)
Search Engine Demand Index44.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (4.35%)5.53%
Reviews4 (5.80%)6.00%
Case Studies1 (1.45%)4.05%
Observational0 (0.00%)0.25%
Other61 (88.41%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]